AMETEK stock (US0311001004): Q1 2026 earnings beat lifts shares

AMETEK reported Q1 2026 EPS of $1.97, topping estimates of $1.90, with revenue at $1.93B versus $1.91B expected. Shares trade around $231 on NYSE.

AMETEK Inc. released its first-quarter 2026 earnings on April 30, 2026, posting adjusted EPS of $1.97, which exceeded the consensus estimate of $1.90 by $0.07, according to MarketBeat as of 05/13/2026. Revenue came in at $1.93 billion, slightly above the $1.91 billion forecast, as noted by Pluang as of 05/14/2026. The stock closed at $231.32 on May 13, 2026, up 0.05% on NYSE.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: AMETEK Inc.
• Sector/industry: Electronic instruments & controls
• Headquarters/country: Berwyn, Pennsylvania, USA
• Core markets: Aerospace, medical, industrial
• Key revenue drivers: EIG and EMG segments
• Home exchange/listing venue: NYSE (AME)
• Trading currency: USD

AMETEK: core business model

AMETEK operates through two main segments: Electronic Instruments Group (EIG) and Electromechanical Group (EMG). EIG focuses on advanced instruments for process, aerospace, power, and medical industries, while EMG provides engineered solutions for aerospace, medical, and industrial applications. The company has grown via acquisitions and operational efficiencies, serving critical markets with high-precision products.

Main revenue and product drivers for AMETEK

Revenue is driven by EIG's process automation and airgas technologies, alongside EMG's motion control and medical systems. In Q1 2026, these segments contributed to the $1.93 billion top line. Aerospace and defense exposure, including components for commercial and military aircraft, bolsters growth amid rising US defense spending.

Industry trends and competitive position

The electronic instruments sector benefits from electrification trends in aerospace and industrial automation. AMETEK holds a strong position with niche leadership in ultraprecision instruments, differentiating via innovation and a global footprint. US investors note its role in supply chains for Boeing and GE Healthcare.

Why AMETEK matters for US investors

Listed on NYSE, AMETEK offers exposure to resilient US industrial and aerospace markets. With headquarters in Pennsylvania, it taps into domestic manufacturing resurgence and benefits from US economic cycles in defense and healthcare.

Conclusion

AMETEK's Q1 2026 results highlight operational strength with an earnings beat and steady revenue growth. The company's focus on high-margin segments positions it amid aerospace recovery. Investors track upcoming quarters for sustained performance in a competitive landscape.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.